A RANDOMIZED DOUBLE-BLIND PLACEBO-CONTROLLED PHASE III STUDY EVALUATING PERIOPERATIVE TORIPALIMAB COMBINED WITH PLATINUM-BASED DOUBLET CHEMOTHERAPY IN RESECTABLE STAGE III NSCLC | |
Wang, Wenxiang2; Wu, Lin2; Zhang, Wei3; Lu, Shun4; Fang, Haohui5; Yu, Guohua6; Zhou, Ming7; Xing, Wenqun8; Chen, Qixun9; Li, Xingya10 | |
刊名 | JOURNAL FOR IMMUNOTHERAPY OF CANCER |
2020-11-01 | |
卷号 | 8 |
DOI | 10.1136/jitc-2020-SITC2020.0366 |
WOS研究方向 | Oncology ; Immunology |
语种 | 英语 |
出版者 | BMJ PUBLISHING GROUP |
WOS记录号 | WOS:000616665300355 |
内容类型 | 期刊论文 |
源URL | [http://ir.hfcas.ac.cn:8080/handle/334002/119581] |
专题 | 中国科学院合肥物质科学研究院 |
作者单位 | 1.Xiamen Univ, Affiliated Hosp 1, Xiamen, Fujian, Peoples R China 2.Hunan Canc Hosp, Changsha, Hunan, Peoples R China 3.Nanchang Univ, Affiliated Hosp 1, Nanchang, Jiangxi, Peoples R China 4.Shanghai Jiao Tong Univ, Shanghai Chest Hosp, Shanghai, Peoples R China 5.Anhui Chest Hosp, Hefei, Anhui, Peoples R China 6.Weifang Peoples Hosp, Weifang, Peoples R China 7.Guangzhou Med Univ, Canc Ctr, Guangzhou, Guangdong, Peoples R China 8.Henan Canc Hosp, Zhengzhou, Henan, Peoples R China 9.Univ Chinese Acad Sci, Zhejiang Canc Hosp, Canc Hosp, Hangzhou, Zhejiang, Peoples R China 10.Zhengzhou Univ, Affiliated Hosp 1, Zhengzhou, Henan, Peoples R China |
推荐引用方式 GB/T 7714 | Wang, Wenxiang,Wu, Lin,Zhang, Wei,et al. A RANDOMIZED DOUBLE-BLIND PLACEBO-CONTROLLED PHASE III STUDY EVALUATING PERIOPERATIVE TORIPALIMAB COMBINED WITH PLATINUM-BASED DOUBLET CHEMOTHERAPY IN RESECTABLE STAGE III NSCLC[J]. JOURNAL FOR IMMUNOTHERAPY OF CANCER,2020,8. |
APA | Wang, Wenxiang.,Wu, Lin.,Zhang, Wei.,Lu, Shun.,Fang, Haohui.,...&Xu, Tao.(2020).A RANDOMIZED DOUBLE-BLIND PLACEBO-CONTROLLED PHASE III STUDY EVALUATING PERIOPERATIVE TORIPALIMAB COMBINED WITH PLATINUM-BASED DOUBLET CHEMOTHERAPY IN RESECTABLE STAGE III NSCLC.JOURNAL FOR IMMUNOTHERAPY OF CANCER,8. |
MLA | Wang, Wenxiang,et al."A RANDOMIZED DOUBLE-BLIND PLACEBO-CONTROLLED PHASE III STUDY EVALUATING PERIOPERATIVE TORIPALIMAB COMBINED WITH PLATINUM-BASED DOUBLET CHEMOTHERAPY IN RESECTABLE STAGE III NSCLC".JOURNAL FOR IMMUNOTHERAPY OF CANCER 8(2020). |
个性服务 |
查看访问统计 |
相关权益政策 |
暂无数据 |
收藏/分享 |
除非特别说明,本系统中所有内容都受版权保护,并保留所有权利。
修改评论